
What's New: Drugs
Generic Drug Facilities, Sites and Organization Lists
Generic Drug Facilities, Sites and Organization Lists
Updated 1/14/2026
Built for U.S. healthcare professionals
Clinical news, specialty coverage, and healthcare industry reporting
Latest Coverage
What's New: Drugs
Generic Drug Facilities, Sites and Organization Lists
What's New: Drugs
FDA’s CDER Small Business and Industry Assistance (SBIA) is making available our YouTube learning library - now hundreds of our recordings are readily accessible.
What's New: Drugs
FDA recognizes the increased use of AI throughout the drug development process and across a range of therapeutic areas. Learn more.
What's New: Drugs
CDER and CBER have collaborated with the European Medicines Agency (EMA) to develop 10 guiding principles that industry and product developers can consider when using artificial intelligence (AI) to advance drug and biological product development.
Audience Fit
Follow healthcare developments, specialty reporting, guideline context, and topics that affect patient care, operations, reimbursement, and care coordination.
Specialty Navigation
Original topic groupings designed for clinicians, care managers, and healthcare operators.
Hypertension, obesity, diabetes, lipid management, and care-pathway coordination.
Screening, biomarkers, survivorship, access barriers, and treatment trends.
Longitudinal strategies for high-prevalence and high-cost condition management.
Prevention, transitions of care, risk segmentation, and quality metric alignment.
Practice Resources
Explore sleep, stress, movement, behavior change, and patient support topics relevant to prevention, counseling, and long-term care planning.
Dietary pattern explainers, counseling language, and adherence barriers.
Sleep, stress, activity, and coaching frameworks that align with clinical care.
Exercise, conditioning, and return-to-function topics for care planning.
Plain-language resources clinicians can reference or adapt at the point of care.